Get started
Author

Daniëlle van Keulen

Observed names: Danielle van Keulen, Daniëlle Van Keulen, van Keulen, Daniëlle
ORCID: 0000-0002-0668-7259
Observed ORCID: 0000-0002-0668-7259
OpenAlex ID: A5020649232
Adeno-associated virus 2 infection in children with non-A–E hepatitis
2023 · Antonia Ho, Richard Orton, et al. · Nature · 201
PDF
Genomic investigations of unexplained acute hepatitis in children
2023 · Sofia Morfopoulou, Sarah Buddle, et al. · Nature · 159
PDF
Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium
2016 · Dries A. M. Feyen, Roberto Gaetani, et al. · Advanced Healthcare Materials · 53
Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice
2018 · Danielle van Keulen, Marianne G. Pouwer, et al. · PLoS ONE · 42
PDF
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature
2023 · Heather R Jackson, Luca Miglietta, et al. · Journal of the Pediatric Infectious Diseases Society · 22
PDF
Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis
2018 · Silvia Aldi, Ljubica Perisic Matic, et al. · Molecular Therapy — Methods & Clinical Development · 21
PDF
Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans
2019 · Danielle van Keulen, Marianne G. Pouwer, et al. · PLoS ONE · 16
PDF
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay
2022 · Rowan Kuiper, Victoria J. Wright, et al. · Pediatric Research · 13
PDF
Common Variants Associated With OSMR Expression Contribute to Carotid Plaque Vulnerability, but Not to Cardiovascular Disease in Humans
2021 · Danielle van Keulen, Ian D. van Koeverden, et al. · Frontiers in Cardiovascular Medicine · 11
PDF
Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis
2022 · Jennifer Venhorst, Tanja Rouhani Rankouhi, et al. · Current Drug Targets · 6
Nested Case-Control and Case-Cohort: Efficient Study Designs to Develop Biomarker-Based Prediction Models for Rare Outcomes
2026 · Barbara Rentroia-Pacheco, Olivia F.M. Steijlen, et al. · Journal of Investigative Dermatology · 4
PDF
Inflammatory Cytokine Oncostatin M Induces Endothelial Activation in vitro and in APOE*3Leiden.CETP Mice
2018 · Danielle van Keulen, Marianne G. Pouwer, et al. · Atherosclerosis Supplements · 1
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature
2023 · Heather R. Jackson, Luca Miglietta, et al. · Newcastle University ePrints (Newcastle Univesity)
Cardiovascular drug target discovery : In vitro and in vivo validation studies
2019 · Daniëlle van Keulen · Utrecht University Repository (Utrecht University)
Abstract 16362: Adenosine Deaminase 2 Inhibits Adenosine-Driven Neutrophil Activation in Atherosclerosis
2017 · Daniëlle van Keulen, Silvia Aldi, et al. · Circulation
Abstract 17220: In Situ Multimodal Molecular Imaging and Staining Technologies Supporting Target Validation in Cardiovascular Disease
2017 · Kim Holmstrøm, Hamm Gregory, et al. · Circulation
Abstract 20282: Lipid Phosphate Phosphatase 3 and Lysophosphatidic Acid Receptors Expression in Human Atherosclerotic Plaques: Co-Localization of Relevant Lipid
2017 · Silvia Aldi, Grégory Hamm, et al. · Circulation
Abstract 19930: Inflammatory Cytokine Oncostatin M Induces Endothelial Activation in vitro and in APOE*3Leiden.CETP Mice
2017 · Daniëlle van Keulen, Marianne G. Pouwer, et al. · Circulation
Works count: 19
Citation count: 549
H-index: 9
I10-index: 9
Year
Topic
Type